Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tatsuki Fukami

Showing results (1-10 of 177) with videos related to

Pageof 18
Sort By:
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|November 3, 2015
[Role of Human Orphan Esterases in Drug-induced Toxicity]Tatsuki Fukami
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|February 1, 2026
[Elucidation of a Novel Protective Function of AADAC Against Drug-induced Liver Injury through Ferroptosis Suppression]Tatsuki Fukami
Drug Metabolism and Pharmacokinetics|July 21, 2012
The emerging role of human esterasesTatsuki Fukami, Tsuyoshi Yokoi
The Journal of Pharmacology and Experimental Therapeutics|July 5, 2019
Adenosine Deaminases Acting on RNA Downregulate the Expression of Constitutive Androstane Receptor in the Human Liver-Derived Cells by Attenuating SplicingMasataka Nakano, Tatsuki Fukami, Miki Nakajima
Drug Metabolism and Pharmacokinetics|December 3, 2025
A novel quantitative assessment of formed reactive metabolites by double trapping with [<sup>3</sup>H]glutathione and [<sup>14</sup>C]cyanideTomoyuki Kawachi, Tatsuki Fukami, Miki Nakajima
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 17, 2015
Characterization of Species Differences in Tissue Diltiazem Deacetylation Identifies Ces2a as a Rat-Specific Diltiazem DeacetylaseTakaya Kurokawa, Tatsuki Fukami, Miki Nakajima
Biochemical Pharmacology|September 27, 2015
A proposed mechanism for the adverse effects of acebutolol: CES2 and CYP2C19-mediated metabolism and antinuclear antibody productionKyotaka Muta, Tatsuki Fukami, Miki Nakajima
Annual Review of Pharmacology and Toxicology|September 9, 2021
Non-P450 Drug-Metabolizing Enzymes: Contribution to Drug Disposition, Toxicity, and DevelopmentTatsuki Fukami, Tsuyoshi Yokoi, Miki Nakajima
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 5, 2026
An in vitro approach to predict idiosyncratic drug-induced agranulocytosis using myeloperoxidase-derived reactive metabolitesTomoyuki Kawachi, Tatsuki Fukami, Miki Nakajima
Biochemical Pharmacology|July 17, 2016
Human arylacetamide deacetylase hydrolyzes ketoconazole to trigger hepatocellular toxicityTatsuki Fukami, Azumi Iida, Keigo Konishi, et al.
Pageof 18

Showing results (1-10 of 177) with videos related to

Sort By:
Pageof 18
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|November 3, 2015
[Role of Human Orphan Esterases in Drug-induced Toxicity]Tatsuki Fukami
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|February 1, 2026
[Elucidation of a Novel Protective Function of AADAC Against Drug-induced Liver Injury through Ferroptosis Suppression]Tatsuki Fukami
Drug Metabolism and Pharmacokinetics|July 21, 2012
The emerging role of human esterasesTatsuki Fukami, Tsuyoshi Yokoi
The Journal of Pharmacology and Experimental Therapeutics|July 5, 2019
Adenosine Deaminases Acting on RNA Downregulate the Expression of Constitutive Androstane Receptor in the Human Liver-Derived Cells by Attenuating SplicingMasataka Nakano, Tatsuki Fukami, Miki Nakajima
Drug Metabolism and Pharmacokinetics|December 3, 2025
A novel quantitative assessment of formed reactive metabolites by double trapping with [<sup>3</sup>H]glutathione and [<sup>14</sup>C]cyanideTomoyuki Kawachi, Tatsuki Fukami, Miki Nakajima
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 17, 2015
Characterization of Species Differences in Tissue Diltiazem Deacetylation Identifies Ces2a as a Rat-Specific Diltiazem DeacetylaseTakaya Kurokawa, Tatsuki Fukami, Miki Nakajima
Biochemical Pharmacology|September 27, 2015
A proposed mechanism for the adverse effects of acebutolol: CES2 and CYP2C19-mediated metabolism and antinuclear antibody productionKyotaka Muta, Tatsuki Fukami, Miki Nakajima
Annual Review of Pharmacology and Toxicology|September 9, 2021
Non-P450 Drug-Metabolizing Enzymes: Contribution to Drug Disposition, Toxicity, and DevelopmentTatsuki Fukami, Tsuyoshi Yokoi, Miki Nakajima
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 5, 2026
An in vitro approach to predict idiosyncratic drug-induced agranulocytosis using myeloperoxidase-derived reactive metabolitesTomoyuki Kawachi, Tatsuki Fukami, Miki Nakajima
Biochemical Pharmacology|July 17, 2016
Human arylacetamide deacetylase hydrolyzes ketoconazole to trigger hepatocellular toxicityTatsuki Fukami, Azumi Iida, Keigo Konishi, et al.
Pageof 18